Claxton Copeland III is a distinguished entrepreneur and the owner and director at Optimal Research Sites LLC
His company specializes in phase I-IV clinical trials for new medications developed by pharmaceutical and biotech companies.
ORANGE CITY, FL, February 06, 2025 /24-7PressRelease/ — Claxton Copeland III has been selected for inclusion in Marquis Who’s Who. As in all Marquis Who’s Who biographical volumes, individuals profiled are selected on the basis of current reference value. Factors such as position, noteworthy accomplishments, visibility, and prominence in a field are all taken into account during the selection process.
Mr. Copeland, owner and director at Optimal Research Sites (ORS) LLC, has been pivotal in clinical research. His leadership, along with the invaluable contributions of his partners Kimberlee Del Campo, Roy Richardson, and Antonio Rivera, has been instrumental in the company’s growth and success. Based in Orange City, Florida, his company specializes in phase I-IV clinical trials for new medications developed by pharmaceutical and biotech companies. Since 2021, Mr. Copeland has overseen research operations, ensuring that services are accessible and comfortable for participants. He also manages the company’s regulatory and compliance aspects and oversees clinical operations to ensure data accuracy. Additionally, Mr. Copeland supports recruitment efforts and collaborates with health care providers on his team. His leadership has been instrumental in the company’s growth and success.
Before launching ORS, Mr. Copeland embarked on his research journey in 2016 as a research assistant. During this time, he gained invaluable experience working with one of Florida’s largest networks, which ranked among the top 10 in enrollment for Pfizer, Moderna and Novavax COVID-19 vaccine trials. This experience was particularly significant during the COVID-19 pandemic when Mr. Copeland’s team was crucial in providing critical vaccine safety and efficacy data. Pfizer notably recognized their efforts with several Appreciation Awards.
Mr. Copeland’s academic background includes a bachelor’s degree in neuropsychology from the University of Central Florida. His education laid the foundation for his career in clinical research, equipping him with the knowledge necessary to excel in his field. Mr. Copeland also holds credentials as a certified clinical research coordinator from the Association of Clinical Research Professionals and is certified in good lab practices.
Besides his education, Mr. Copeland has been active as a member of the Association of Clinical Research Professionals. In light of his success, he was named one of Orlando Family Magazine’s Men of the Year in 2024. This recognition highlights his contributions to the community and his impact on advancing health care access and diversity.
Mr. Copeland attributes his success to cultivating genuine relationships and fostering solid connections, which enable him to acquire the support he needs to excel in his field. His dedication to supporting others has also been a significant factor in his achievements.
Committed to fostering continued growth within ORS, Mr. Copeland, along with Kimberlee Del Campo, Roy Richardson, and Antonio Rivera, intends to open a second overnight facility for phase one trials involving human subjects.
About Marquis Who’s Who®:
Since 1899, when A. N. Marquis printed the First Edition of Who’s Who in America®, Marquis Who’s Who® has chronicled the lives of the most accomplished individuals and innovators from every significant field of endeavor, including politics, business, medicine, law, education, art, religion and entertainment. Who’s Who in America® remains an essential biographical source for thousands of researchers, journalists, librarians and executive search firms around the world. The suite of Marquis® publications can be viewed at the official Marquis Who’s Who® website, www.marquiswhoswho.com.
# # #
